Charts

Middle East and Africa Irritable Bowel Syndrome Treatment Market By Drug Type Forecast (2015-2023)

Linaclotide segment accounted for the largest market share in 2017, this market is expected to reach usd 66.00 million in 2023 from usd 46.60 million in 2017. this market is projected to grow at a cagr of 5.50% during the forecast period from 2018

Middle East and Africa Irritable Bowel Syndrome Treatment Market By End User Forecast (2015-2023)

Hospitals segment accounted for the largest market share in 2017, this market is expected to reach usd 86.40 million in 2023 from usd 60.70 million in 2017. this market is projected to grow at a cagr of 5.60% during the forecast period from 2018 -

Middle East and Africa Irritable Bowel Syndrome Treatment Market Forecast (2015-2023)

Middle-east accounted for the larger market share in 2017 in the middle east and africa irritable bowel syndrome treatment market, and is expected to reach usd 139.30 million in 2023 from usd 101.50 million in 2017. however, africa is the fastest g

North America Irritable Bowel Syndrome Treatment Market By Type Forecast (2015-2023)

Ibs d segment accounted for the largest market share in 2017, this market is expected to reach usd 642.40 million in 2023 from usd 380.00 million in 2017. this market is projected to grow at a cagr of 9.02% during the forecast period from 2018 - 20

North America Irritable Bowel Syndrome Treatment Market By Drug Type Forecast (2015-2023)

Linaclotide segment accounted for the largest market share in 2017, this market is expected to reach usd 343.90 million in 2023 from usd 207.40 million in 2017. this market is projected to grow at a cagr of 8.66% during the forecast period from 201

North America Irritable Bowel Syndrome Treatment Market By End User Forecast (2015-2023)

Hospitals segment accounted for the largest market share in 2017, this market is expected to reach usd 450.40 million in 2023 from usd 270.10 million in 2017. this market is projected to grow at a cagr of 8.76% during the forecast period from 2018

North America Irritable Bowel Syndrome Treatment Market Forecast (2015-2023)

United states accounted for the larger market share in 2017 in the north america irritable bowel syndrome treatment market, and is expected to reach usd 886.30 million in 2023 from usd 544.20 million in 2017. however, canada is the fastest growing

Asia Pacific Irritable Bowel Syndrome Treatment Market By Type Forecast (2015-2023)

Ibs d segment accounted for the largest market share in 2017, this market is expected to reach usd 308.40 million in 2023 from usd 201.50 million in 2017. this market is projected to grow at a cagr of 6.89% during the forecast period from 2018 - 20

Asia Pacific Irritable Bowel Syndrome Treatment Market By Drug Type Forecast (2015-2023)

Linaclotide segment accounted for the largest market share in 2017, this market is expected to reach usd 165.10 million in 2023 from usd 110.00 million in 2017. this market is projected to grow at a cagr of 6.54% during the forecast period from 201

Asia Pacific Irritable Bowel Syndrome Treatment Market By End User Forecast (2015-2023)

Hospitals segment accounted for the largest market share in 2017, this market is expected to reach usd 216.20 million in 2023 from usd 143.20 million in 2017. this market is projected to grow at a cagr of 6.62% during the forecast period from 2018